Drug
Treg Enriched Infusion
Treg Enriched Infusion: highest development phase Phase 1, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Treg-enriched infusion NCT01937468 | Phase 1 | Chronic Graft Versus Host Disease |
Latest
No recent events.
Follow Treg Enriched Infusion on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.